These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Flaws in design, execution and interpretation limit CLARITY-BPA's value for risk assessments of bisphenol A. Vom Saal FS Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3():32-43. PubMed ID: 30589220 [TBL] [Abstract][Full Text] [Related]
4. NIEHS/FDA CLARITY-BPA research program update. Heindel JJ; Newbold RR; Bucher JR; Camacho L; Delclos KB; Lewis SM; Vanlandingham M; Churchwell MI; Twaddle NC; McLellen M; Chidambaram M; Bryant M; Woodling K; Gamboa da Costa G; Ferguson SA; Flaws J; Howard PC; Walker NJ; Zoeller RT; Fostel J; Favaro C; Schug TT Reprod Toxicol; 2015 Dec; 58():33-44. PubMed ID: 26232693 [TBL] [Abstract][Full Text] [Related]
5. Achieving CLARITY on bisphenol A, brain and behaviour. Patisaul HB J Neuroendocrinol; 2020 Jan; 32(1):e12730. PubMed ID: 31063678 [TBL] [Abstract][Full Text] [Related]
6. Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Birnbaum LS; Bucher JR; Collman GW; Zeldin DC; Johnson AF; Schug TT; Heindel JJ Environ Health Perspect; 2012 Dec; 120(12):1640-4. PubMed ID: 23052487 [TBL] [Abstract][Full Text] [Related]
7. The Use and Misuse of Historical Controls in Regulatory Toxicology: Lessons from the CLARITY-BPA Study. Vandenberg LN; Prins GS; Patisaul HB; Zoeller RT Endocrinology; 2020 May; 161(5):. PubMed ID: 31690949 [TBL] [Abstract][Full Text] [Related]
8. CLARITY-BPA: Effects of chronic Bisphenol A exposure on the immune system: Part 1 - Quantification of the relative number and proportion of leukocyte populations in the spleen and thymus. Li J; Bach A; Crawford RB; Phadnis-Moghe AS; Chen W; D'Ingillo S; Kovalova N; Suarez-Martinez JE; Zhou J; Kaplan BLF; Kaminski NE Toxicology; 2018 Mar; 396-397():46-53. PubMed ID: 29428349 [TBL] [Abstract][Full Text] [Related]
9. Endocrine disruptors and the future of toxicology testing - lessons from CLARITY-BPA. Vandenberg LN; Hunt PA; Gore AC Nat Rev Endocrinol; 2019 Jun; 15(6):366-374. PubMed ID: 30842650 [TBL] [Abstract][Full Text] [Related]
11. Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies. Heindel JJ; Belcher S; Flaws JA; Prins GS; Ho SM; Mao J; Patisaul HB; Ricke W; Rosenfeld CS; Soto AM; Vom Saal FS; Zoeller RT Reprod Toxicol; 2020 Dec; 98():29-60. PubMed ID: 32682780 [TBL] [Abstract][Full Text] [Related]
12. Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol A as a case study. Tyl RW Environ Health Perspect; 2009 Nov; 117(11):1644-51. PubMed ID: 20049112 [TBL] [Abstract][Full Text] [Related]
13. Evaluating endocrine disrupting chemicals: A perspective on the novel assessments in CLARITY-BPA. Howdeshell KL; Beverly BEJ; Blain RB; Goldstone AE; Hartman PA; Lemeris CR; Newbold RR; Rooney AA; Bucher JR Birth Defects Res; 2023 Sep; 115(15):1345-1397. PubMed ID: 37646438 [TBL] [Abstract][Full Text] [Related]
14. Bisphenol A: Update on newly developed data and how they address NTP's 2008 finding of "Some Concern". Shelnutt S; Kind J; Allaben W Food Chem Toxicol; 2013 Jul; 57():284-95. PubMed ID: 23567242 [TBL] [Abstract][Full Text] [Related]
15. Nanotoxicology and nanotechnology: new findings from the NIEHS and Superfund Research Program scientific community. Carlin DJ Rev Environ Health; 2014; 29(1-2):105-7. PubMed ID: 24695034 [TBL] [Abstract][Full Text] [Related]
16. The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA). Vom Saal FS; Antoniou M; Belcher SM; Bergman A; Bhandari RK; Birnbaum LS; Cohen A; Collins TJ; Demeneix B; Fine AM; Flaws JA; Gayrard V; Goodson WH; Gore AC; Heindel JJ; Hunt PA; Iguchi T; Kassotis CD; Kortenkamp A; Mesnage R; Muncke J; Myers JP; Nadal A; Newbold RR; Padmanabhan V; Palanza P; Palma Z; Parmigiani S; Patrick L; Prins GS; Rosenfeld CS; Skakkebaek NE; Sonnenschein C; Soto AM; Swan SH; Taylor JA; Toutain PL; von Hippel FA; Welshons WV; Zalko D; Zoeller RT Environ Health Perspect; 2024 Apr; 132(4):45001. PubMed ID: 38592230 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Bisphenol A (BPA) Exposures on Prostate Stem Cell Homeostasis and Prostate Cancer Risk in the NCTR-Sprague-Dawley Rat: An NIEHS/FDA CLARITY-BPA Consortium Study. Prins GS; Hu WY; Xie L; Shi GB; Hu DP; Birch L; Bosland MC Environ Health Perspect; 2018 Nov; 126(11):117001. PubMed ID: 30387366 [TBL] [Abstract][Full Text] [Related]
18. A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results. Camacho L; Lewis SM; Vanlandingham MM; Olson GR; Davis KJ; Patton RE; Twaddle NC; Doerge DR; Churchwell MI; Bryant MS; McLellen FM; Woodling KA; Felton RP; Maisha MP; Juliar BE; Gamboa da Costa G; Delclos KB Food Chem Toxicol; 2019 Oct; 132():110728. PubMed ID: 31365888 [TBL] [Abstract][Full Text] [Related]
19. Contested evidence: Exposure to competing scientific claims and public support for banning bisphenol A. Brewer PR; Ley BL Public Underst Sci; 2014 May; 23(4):395-410. PubMed ID: 23825248 [TBL] [Abstract][Full Text] [Related]